Cardiovascular Systems Inc
F:R7Y1
Gross Margin
Cardiovascular Systems Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
C
|
Cardiovascular Systems Inc
F:R7Y1
|
755.4m EUR |
72%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
237.8B USD |
56%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
158.9B USD |
67%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.5B USD |
65%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
143.1B USD |
68%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
122.1B USD |
65%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.7B EUR |
39%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
53.2B USD |
45%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.4B USD |
62%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.3B USD |
79%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
287.5B CNY |
59%
|
Cardiovascular Systems Inc
Glance View
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 780 full-time employees. The company went IPO on 2006-06-28. The firm has developed patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Cardiovascular Systems Inc's most recent financial statements, the company has Gross Margin of 72.4%.
You don't have any saved screeners yet